arrow
D

Dag Henrik Reikvam

karolinska institutet
H指数:15
被引数:1,330

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B

HBeAg阴性乙型肝炎患者核苷(酸)类似物停药后的肝功能flare、免疫特征及ALT变异性

2026-06-011
OA
Long-term HIV-1 remission achieved through allogeneic haematopoietic stem cell transplant from a CCR5Δ32/Δ32 sibling donor

通过CCR5Δ32/Δ32同胞供体异基因造血干细胞移植实现长期HIV-1缓解

2026-04-130
OAAI
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort

慢性乙型肝炎核苷 (酸) ide类似物停止后的长期结果-RETRACT-B队列的随访

2026-03-300
OAAI
Geography-independent mucosal microbiota alterations in primary sclerosing cholangitis persist after liver transplantation

地理无关的黏膜微生物群改变在原发性硬化性胆管炎患者中肝移植后持续存在

2025-12-220
OAAI
Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B
2024-07-055
OAAI
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

TLR9激动剂和广泛中和抗体对HIV-1持久性的影响: TITAN 2a期随机试验

2023-09-1123
OAAI
Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV

HIV感染者自杀、药物使用导致死亡和暴力/意外死亡的发生率和危险因素

AIDS
IF3.1
2022-10-113
PRE
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort
AIDS
IF3.1
2018-10-2393
OAAI